XML 65 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Commitments and Contingencies (Details)
$ in Millions
Jun. 30, 2018
USD ($)
License Agreements | Archemix | C5 Licensed Product | Achievement of specified clinical and regulatory milestones | Maximum  
Commitments and contingencies  
Amount to be paid on achievement of milestone $ 57.5
License Agreements | Archemix | C5 Licensed Product | First indication | Maximum  
Commitments and contingencies  
Amount to be paid on achievement of milestone 30.5
License Agreements | Archemix | C5 Licensed Product | Second and third indication | Maximum  
Commitments and contingencies  
Amount to be paid on achievement of milestone 24.5
License Agreements | Archemix | C5 Licensed Product | Sustained delivery applications | Maximum  
Commitments and contingencies  
Amount to be paid on achievement of milestone 2.5
License Agreements | Archemix | C5 Licensed Product | Achievement of specified commercial milestones | Maximum  
Commitments and contingencies  
Amount to be paid on achievement of milestone 22.5
RHO-adRP License Agreement | University of Florida Research Foundation (UFRF) | Specified clinical, marketing approval and reimbursement approval milestones with respect to a licensed product  
Commitments and contingencies  
Amount to be paid on achievement of milestone 23.5
RHO-adRP License Agreement | University of Florida Research Foundation (UFRF) | Specified commercial sales milestones with respect to a licensed product  
Commitments and contingencies  
Amount to be paid on achievement of milestone $ 70.0